[-] Show simple item record

dc.contributor.authorSkladzien, Stephanieen_US
dc.contributor.authorDresang, Lee T.en_US
dc.date.issued2010-10
dc.description.abstractSupplementation with intramuscular 17-alpha hydroxyprogesterone caproate (17P) significantly reduces the incidence of preterm delivery for women at increased risk of preterm birth. All women with a singleton pregnancy and a history of prior preterm birth should be offered weekly injections. Additional studies are needed to investigate use in women with a short cervix, multiple gestations, and in arrest of preterm labor. Complete maternal and fetal safety profiles, as well as ideal dose, route of administration, and duration of treatment, are also evolving.en_US
dc.identifier.citationEvidence Based Practice 13(10): 11.en_US
dc.identifier.urihttp://hdl.handle.net/10355/9448
dc.publisherFamily Physicians Inquiries Networken_US
dc.relation.ispartofEvidence Based Practice 13(10): 11.en_US
dc.relation.ispartofcollectionEvidence Based Practice, 2010en_US
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. Evidence Based Practice.en_US
dc.subjectdelivery ratesen_US
dc.subjectprogesterone therapyen_US
dc.subject.lcshLabor (Obstetrics)en_US
dc.subject.lcshDelivery (Obstetrics)en_US
dc.subject.lcshProgesteroneen_US
dc.title17-Alpha hydroxyprogesterone for reducing preterm laboren_US
dc.typeArticleen_US


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record